Molecular Genetics of Cancers
Keywords:
Molecular genetics, CancerAbstract
Advances in the molecular genetic of cancer in the last 15 years have made significant impact on patient management. The application of new technologies in molecular genetics and immunology may provide the clini-cians with the tools to enhance patient survival. The focus of this review is to provide a brief simplified descrip-tion of the basic science of molecular genetics using head and neck cancer as a model and to outline potential applications and limitations of our current knowledge.
References
Weinberg R. The molecular basis of oncogenes and tumor sup-pressor genes. Ann N Y Acad Sci 1995;758:331-8.
Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
Almoguera C, Shibata D, Forrester K, et al. Most human carci-nomas of the exocrine pancreas contain mutant c-K-rad genes. Cell 1988;53:549-54.
Masuda H, Miller C, Koeffler HP, et al. Rearrangement of the p53 gene in human osteogenic sarcoma. Proc Nat Acad Sci (USA) 1987;84:7716-9.
Fearon E, Hamilton S, Vogelstein B. Clonal analysis of human colorectal tumours. Science 1987;238:193-7.
Cheng L, Sturgis E, Eicher S, et al. Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer 1999;84:220-4.
Wang L, Sturgis E, Eicher S, et al. Mutagen sensitivity to benzo(a) pyrene diol epoxide and the risk of squamous cell carcinomas of the head and neck. Clin Cancer Res 1998;4:1773-8.
Van Dyke D, Worsham M, Benninger M, et al. Recurrent cyto-genic abnormalities in squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 1994;9:192-206.
Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancer-ization. Cancer Res 1996;56:2488-92.
Partridge M. Current status of genetics for prediction, prognosis, and gene therapy. Curr Opinion Otolaryngol & Head Neck Surg 2000;8:69-79.
Cowan J, Beckett M, Weichselbaum R. Chromosome changes characterising in vitro response to radiation in human squamous cell carcinoma lines. Cancer Res 1993;53:5542-7.
O-charoenrat P, Rhys-Evans PH, Archer DJ, Eccles SA. The role of c-erb B family of receptors in head and neck squamous cell carcinomas. Oral Oncol 2002;38:627-40.
O-charoenrat P, Rhys-Evans P, Eccles SA. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erb B proto-oncogene expression. Anticancer Res 2001;21:1953-63.
O-charoenrat P, Rhys-Evans P, Court WJ, et al. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erb B ligands. Clin Exp Metastasis 1999; 17:631-9.
O-charoenrat P, Rhys-Evans P, Modjtahedi H, Eccles SA. Vascu-lar endothelial growth factor family members are differentially regulated by c-erb B signaling in head and neck squamous carcinoma cells. Clin Exp Metastasis 2000;18:155-61.
O-charoenrat P, Modjtahedi H, Rhys-Evans P, et al. Epidermal growth factor-like ligands differentially upregulate matrix me-talloproteinase-9 in head and neck squamous carcinoma cells. Cancer Res 2000;60:1121-8.
O-charoenrat P, Rhys-Evans P, Eccles SA. Expression and re-gulation of c-erb B ligands in human head and neck squamous carcinoma cells. Int J Cancer 2000;88:759-65.
Tadokoro K, Ueda M, Ohshima T, et al. Activation of oncoge-nes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplification of c-erb-B-1 and c-myc. Oncogene 1989;4:499-505.
Anderson J, Irish J, Ngan B-Y. Prevalence of Ras oncogene mutations in head and neck carcinomas. J Otolaryngol 1992; 21:321-6.
Bova R, Quinn D, Nankervis J, et al. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999;5:2810-9.
Rodrigo J, Garcia L, Ramos S, et al. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 2000;6: 3177-82.
Resto V, Caballero O, Buta M, et al. A putative oncogenic role for MPP11 in head and neck squamous cell cancer. Cancer Res 2000;60:5529-35.
Nawroz H, van der Riet P, Hruban R, et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994; 54:1152-5.
Reed A, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squa-mous cell carcinoma. Cancer Res 1996;56:3630-3.
Boyle J, Hakim J, Kock W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993;53:4477-80.
Brennan J, Mao L, Hruban R, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-35.
Homann N, Nees M, Conradt C, et al. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary car-cinoma. Clin Cancer Res 2001;7:290-6.
Tanimoto K, Hayashi S, Tsuchiya E, et al. Abnormalities of the FHIT gene in human oral carcinogenesis. Br J Cancer 2000;82:838-43.
Nakanishi H, Wang XL, Imai F, et al. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer. Anticancer Res 1999;19:29-34.
Voravud N, Shin D, Ro J, et al. Increased polysomies of chromo-somes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 1993;53:2874-83.
Mao L, Lee J, Fan Y, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Med 1996;2:682-5.
Partridge M, Emillion G, Pateromichelakis S, et al. Allelic imbal-ance at chromosomal loci implicated in the pathogenesis of oral precancer; cumulative loss and its relationship with progression to cancer. Oral Oncol Eur J Cancer 1997;34:77-83.
Califano J, Westra W, Koch W, et al. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 1999;91: 599-604.
Snyderman C, D’Amico F, Wagner R, Eibling D. A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Arch Otolaryngol Head Neck Surg 1995; 121:1294-7.
Yen T, Lin W, Kao C, et al. A study of a new marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Oto-laryngol Allied Sci 1998;23: 82-6.
Fazekas-May M, Suen J, Yeh Y, et al. Investigation of urinary transforming growth factor alpha levels as tumor markers in patients with advanced squamous cell carcinoma of the head and neck. Head Neck 1990;12:411-6.
Lo Y, Chan L, Lo K, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopha-ryngeal carcinoma. Cancer Res 1999;59:1188-91.
Capone R, Pai S, Koch W, et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 2000;6:4171-5.
O-charoenrat P, Rusch V, Talbot S, et al. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung. Clin Cancer Res 2004;10:5792-803.
Stroomer J, Roos J, Sproll M, et al. Safety and biodistribution of 99mTechnitium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients. Clin Cancer Res 2000; 6: 3046-55.
O-charoenrat P, Rhys-Evans PH, Archer DJ, Eccles SA. C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloprotei-nases and vascular endothelial growth factors. Oral Oncol. 2002;38:73-80.
Xia W, Lau Y-K, Zhang H-Z, et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 1999;5:4164-74.
O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2001;127:813-20.
O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastases. Cancer 2001;92:556-68.
O-charoenrat P, Rhys-Evans P, Modjtahedi H, et al. Over-expression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer 2000;86:307-17.
Kawakami K, Leland P, Puri R. Structure, function, and target-ing of interleukin 4 receptors on human head and neck cancer cells. Cancer Res 2000;60:2981-7.
Clayman G, Frank D, Bruso P, Goepfert H. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clin Cancer Res 1999; 5: 1715-22.
Yu Z, Chan MK, O-charoenrat P, et al. Enhanced nectin-1 ex-pression and herpes oncolytic sensitivity in highly migratory and invasive carcinoma. Clin Cancer Res 2005;11: 4889-97.
Heise C, Sampson-Johannes A, Williams A, et al. ONYX-015, an E1B gene-attenuated adenovirus, causes cytolysis and an-titumoral efficacy that can be augmented by standard chemo-therapeutic agents. Nature Med 1997;3:639-45.
Downloads
Published
How to Cite
Issue
Section
License
Articles must be contributed solely to The Thai Journal of Surgery and when published become the property of the Royal College of Surgeons of Thailand. The Royal College of Surgeons of Thailand reserves copyright on all published materials and such materials may not be reproduced in any form without the written permission.
